GoodRx Holdings, Inc.
For the period ended Dec 31, 2025. Filed Feb 26, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 26, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
None.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| GOODRX HOLDINGS, INC. | ||
| Date: February 25, 2026 | By: | /s/ Christopher McGinnis |
|---|---|---|
| Christopher McGinnis | ||
| Chief Financial Officer & Treasurer | ||
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following
persons on behalf of the registrant in the capacities and on the dates indicated.
| Name | Title | Date |
|---|---|---|
| /s/ Wendy Barnes | Chief Executive Officer & President | February 25, 2026 |
| Wendy Barnes | (Principal Executive Officer) | |
| /s/ Christopher McGinnis | Chief Financial Officer & Treasurer | February 25, 2026 |
| Christopher McGinnis | (Principal Financial Officer) | |
| /s/ Romin Nabiey | Chief Accounting Officer | February 25, 2026 |
| Romin Nabiey | (Principal Accounting Officer) | |
| /s/ Trevor Bezdek | Co-Chairman of the Board | February 25, 2026 |
| Trevor Bezdek | ||
| /s/ Scott Wagner | Co-Chairman of the Board | February 25, 2026 |
| Scott Wagner | ||
| /s/ Christopher Adams | Director | February 25, 2026 |
| Christopher Adams | ||
| /s/ Ronald E. Bruehlman | Director | February 25, 2026 |
| Ronald E. Bruehlman | ||
| /s/ Ian T. Clark | Director | February 25, 2026 |
| Ian T. Clark | ||
| /s/ Dipanjan Deb | Director | February 25, 2026 |
| Dipanjan Deb | ||
| /s/ Douglas Hirsch | Director | February 25, 2026 |
| Douglas Hirsch | ||
| /s/ Kelly J. Kennedy | Director | February 25, 2026 |
| Kelly J. Kennedy | ||
| /s/ Gregory Mondre | Director | February 25, 2026 |
| Gregory Mondre | ||
| /s/ Agnes Rey-Giraud | Director | February 25, 2026 |
| Agnes Rey-Giraud | ||
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
| Page | |
| Report of Independent Registered Public Accounting Firm (PCAOB ID 238) | F-1 |
|---|---|
| Consolidated Balance Sheets | F-3 |
| Consolidated Statements of Operations | F-4 |
| Consolidated Statements of Stockholders’ Equity | F-5 |
| Consolidated Statements of Cash Flows | F-6 |
| Notes to Consolidated Financial Statements | F-8 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.